Compare Bank of Nova Scotia (BNS) vs Cardinal Health Inc (CAH) Price & Performance

Bank of Nova ScotiaTrade

Cardinal Health IncTrade

Price performance (Past 24H)

Key statistics

Bank of Nova Scotia vs Cardinal Health Inc — how do they compare? Bank of Nova Scotia trades at $89.03 (market cap $108.32B), while Cardinal Health Inc trades at $240.57 (market cap $55.88B). The key difference: Bank of Nova Scotia is the larger of the two by market cap, and Bank of Nova Scotia pays the higher dividend (3.64%). Which is the better fit depends on your goals.

	BNS	CAH
Market Cap	$108.32B	$55.88B
Sector	Financials	Health
52-Week High	$90.29	$240.26
52-Week Low	$56.41	$146.04
Dividend Yield	3.64%	0.86%
Enterprise Value	—	$59.91B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BNS

View details →

CAH

Cardinal Health beats Q4 EPS estimates by 20% despite missing revenue targets.Stuart Mooney · 21 hours agoBullish Cardinal Health Q4 revenue up 6%, EPS rises 70%, FY27 EPS guidance raised to $12.40-$12.60PRNewsWire · 1 day agoBullish Cardinal Health declares $0.5158 quarterly dividend payable October 15, 2026PRNewsWire · 1 day agoNeutral View details →

About Bank of Nova Scotia

Bank of Nova Scotia is a global financial services provider. The bank has five business segments: Canadian banking, international banking, global wealth management, global banking and markets, and other. It offers a range of advice, products, and services, including personal and commercial banking, wealth management and private banking, corporate and investment banking, and capital markets. The bank's international operations span numerous countries and are more concentrated in Central and South America.

About Cardinal Health Inc

Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.